Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts - Table 2

Associations with discontinuations due to adverse drug reactions in a. enhanced-data patients (n = 3 837) and b. routine-data patients (n = 11 559) from two South African cohorts, who initiated antiretroviral treatment from 2010–2013.